Assuming that elevation of the default tyrosine kinase function of EGFR, owning to over-expression or kinase activating mutations, is all that cancer cells depend on in driving malignancy, the canonical tyrosine kinase function of EGFR has served as a beacon directing the design of EGFR targeted therapies for cancer. Here, EGFR is linked to cancer.